Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8053)
All Articles published online
|
Publishing Process of This Article
|
Feb 15, 2020 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kaiser K, Lyleroehr M, Shaunfield S, Lacson L, Corona M, Kircher S, Nittve M, Cella D. Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale. World J Gastrointest Oncol 2020; 12(2): 205-218 [PMID: 32104551 DOI: 10.4251/wjgo.v12.i2.205] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v12/i2/205.htm |
| Number | Citing Articles |
| 1 |
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Farid Hashemi, Fardin Hashemi, Saeed Samarghandian, Masoud Najafi. MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer. Life Sciences 2020; 256: 117973 doi: 10.1016/j.lfs.2020.117973
|
| 2 |
Chien-Chen Huang, Tsung-Jung Ho, Hsin-Yueh Ho, Pei-Yu Chen, Cheng-Hao Tu, Yu-Chuen Huang, Yu-Chen Lee, Mao-Feng Sun, Yi-Hung Chen. Acupuncture Relieved Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast Cancer: A Pilot Randomized Sham-Controlled Trial. Journal of Clinical Medicine 2021; 10(16): 3694 doi: 10.3390/jcm10163694
|
| 3 |
Tomislav Vlaski, Marija Slavic, Reiner Caspari, Bettine Bilsing, Harald Fischer, Hermann Brenner, Ben Schöttker. From a Clustering of Adverse Symptoms after Colorectal Cancer Therapy to Chronic Fatigue and Low Ability to Work: A Cohort Study Analysis with 3 Months of Follow-Up. Cancers 2024; 16(1): 202 doi: 10.3390/cancers16010202
|
| 4 |
Mohammad Alsalem, Amr Ellaithy, Sarah Bloukh, Mansour Haddad, Tareq Saleh. Targeting therapy-induced senescence as a novel strategy to combat chemotherapy-induced peripheral neuropathy. Supportive Care in Cancer 2024; 32(1) doi: 10.1007/s00520-023-08287-0
|
| 5 |
Jamie Burgess, Maryam Ferdousi, David Gosal, Cheng Boon, Kohei Matsumoto, Anne Marshall, Tony Mak, Andrew Marshall, Bernhard Frank, Rayaz A. Malik, Uazman Alam. Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment. Oncology and Therapy 2021; 9(2): 385 doi: 10.1007/s40487-021-00168-y
|
| 6 |
Lili Lu, Randy Przybylla, Yuru Shang, Meng Dai, Mathias Krohn, Oliver Holger Krämer, Christina Susanne Mullins, Michael Linnebacher. Microsatellite Status and IκBα Expression Levels Predict Sensitivity to Pharmaceutical Curcumin in Colorectal Cancer Cells. Cancers 2022; 14(4): 1032 doi: 10.3390/cancers14041032
|
| 7 |
Tiffany Li, Susanna B. Park, Eva Battaglini, Madeleine T. King, Matthew C. Kiernan, David Goldstein, Claudia Rutherford. Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use. Quality of Life Research 2022; 31(11): 3091 doi: 10.1007/s11136-022-03154-7
|
| 8 |
Kelly R. Voigt, Lissa Wullaert, M. H. Elise van Driel, Max Goudberg, Pascal G. Doornebosch, Jennifer M. J. Schreinemakers, Maria Verseveld, Koen C. M. J. Peeters, Cornelis Verhoef, Olga Husson, Dirk J. Grünhagen. The association of cognitive coping style with patient preferences in a patient-led follow-up study among colorectal cancer survivors. Supportive Care in Cancer 2024; 32(8) doi: 10.1007/s00520-024-08758-y
|
| 9 |
Housem Kacem, Annamaria Cimini, Michele d’Angelo, Vanessa Castelli. Molecular and Cellular Involvement in CIPN. Biomedicines 2024; 12(4): 751 doi: 10.3390/biomedicines12040751
|
| 10 |
Guoqiong Lei, Sushun Liu, Xin Yang, Chao He, Ravindran Caspa Gokulan. TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/8870907
|
| 11 |
Per Pfeiffer, Maryam Lustberg, Jacques Näsström, Stefan Carlsson, Anders Persson, Fumiko Nagahama, Guido Cavaletti, Bengt Glimelius, Kei Muro. Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M). JNCI Cancer Spectrum 2022; 6(6) doi: 10.1093/jncics/pkac075
|
| 12 |
Seohyuk Lee, Chao Ma, Qian Shi, Pankaj Kumar, Felix Couture, Philip Kuebler, Smitha Krishnamurthi, DeQuincy Lewis, Benjamin Tan, Richard M. Goldberg, Alan Venook, Charles Blanke, Eileen M. O'Reilly, Anthony F. Shields, Jeffrey A. Meyerhardt. Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702. Journal of Clinical Oncology 2023; 41(5): 1079 doi: 10.1200/JCO.22.01637
|